Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
NCT04383808 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-04-06
Summary
The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.
Conditions
- Brain Disease
Interventions
- DIAGNOSTIC_TEST
-
Injected radiotracer with PET Insert
1. Informed consent will be obtained before beginning any study procedures. 2. Participants will receive a small quantity of an FDA approved radiotracer. The PET insert is placed within a 3T MRI scanner, where PET and MRI imaging will be completed.
- DIAGNOSTIC_TEST
-
Pre-injected group with PET insert
1. Informed consent will be obtained before beginning any study procedures. 2. Participants who have received radiotracer for another PET imaging system. The PET insert is placed within a 3T MRI scanner, where PET and MRI imaging will be completed.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2027-03-31
- Completion
- 2028-03-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain
NCT01896843 ·Status: COMPLETED ·Phase: PHASE1
-
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT05003830 ·Status: UNKNOWN
-
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
NCT05260151 ·Status: UNKNOWN
-
FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD
NCT04311281 ·Status: WITHDRAWN
-
11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation
NCT02811744 ·Status: TERMINATED ·Phase: PHASE2
-
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 ·Status: RECRUITING
-
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
NCT01680588 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
NCT05374278 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
NCT02676843 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
MRI Assessing Clinical Usability of STrategically Acquired Gradient Echo on Human Participants
NCT04292301 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
NCT02531360 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET/MR Multimodal Quantitative Analysis of CBF and CMRGlc in Cerebral Ischemia
NCT07079345 ·Status: RECRUITING
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING
-
Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein
NCT03071224 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
NCT01992380 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
NCT07115238 ·Status: RECRUITING ·Phase: PHASE3
-
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
NCT03514524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
NCT02370524 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513
NCT01000870 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
NCT02003183 ·Status: COMPLETED